HRT Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
CIA
OMC
TFA
JF
TCM
HRT Financial's BIB Position: Q1 2022 in Review
HRT Financial sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2022, closing a stake of 6,616 shares — an estimated $536K sold.
HRT Financial first reported a position in BIB in Q2 2016 and held it in 12 quarters. The position peaked at $3.46M in Q4 2020. 28 funds tracked by Wall St. Rank hold BIB as of Q1 2022.
- HRT Financial reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2022 after selling out during the quarter.
- HRT Financial sold 6,616 ProShares Ultra NASDAQ Biotechnology shares in Q1 2022, an estimated $536K.
- HRT Financial first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2016 and held it in 12 quarters.
- HRT Financial's ProShares Ultra NASDAQ Biotechnology position peaked at $3.46M in Q4 2020.
- 28 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2022.
Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.